CGT

24개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved24 programs
CGTAAVLimited DatastaleElisigen, Inc.Phase 2

NG101 AAV gene therapy (NG101 AAV gene therapy)

Age-Related Macular Degeneration · Age-Related Macular Degeneration

#Age-RelatedMacularDegeneration#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleZhujiang HospitalPhase 1

Sequential Treatment With different CART (Sequential Treatment With different CART)

Therapy Related Leukemia · Therapy Related Leukemia

#TherapyRelatedLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleCity of Hope Medical CenterPhase 1

lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells (lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells)

AIDS-related Non-Hodgkin Lymphoma; AIDS-related Plasmablastic Lymphoma · AIDS-related Non-Hodgkin Lymphoma

#AIDS-relatedNon-HodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleLions Eye Institute, Perth, Wes…Phase 2

rAAV.sFlt-1 (rAAV.sFlt-1)

Macular Degeneration; Age-related Maculopathies · Macular Degeneration

#MacularDegeneration#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active

2 / 2 pages

← PreviousNext →